SWOG S1007 – A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less

NSABP B-47 A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone(Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer

NSABP-B-49 - A Phase III Clinical Trial Comparing the Combination of
Docetaxel plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

CLL
CELGENE CONNECT CLL The Chronic Lymphocytic Leukemia Disease Registry

CML
BRISTOL-MYERS SQUIBB CA180330 – Studying Interventions for Managing Patients with Chronic Myeloid Leukemia in Chronic Phase: the 5 year
prospective Cohort Study (SIMPLICITY)

 

ECOG E5508 – Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced non Squamous NSCLC

 

CALGB 50604 - Phase II Trial of Response-Adapted Chemotherapy Based on Positron Emission Tomography for Non-Bulky Stage I and II Hodgkin Lymphoma

SWOG S0816 - A Phase II Trial of Response-Adapted Therapy of Stage III-IV Hodgkin Lymphoma using Early Interim FDG-PET Imaging

 

ECOG E1609 - A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-risk Melanoma 

 

ECOG E3A06 - Randomized Phase III Trial of Lenalidomide versus Observation Alone in Patients with Asymptomatic High-Risk Multiple Myeloma 
 

ECOG E4805 - A Randomized, Phase II Study to Determine the Effect of Two Different Doses of AVE0005 (VGEF Trap) in Patients with Metastatic Renal Cell Carcinoma 
 

CALGB 90601 - A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma
 
For more information please contact:

Clinical Research Office
Medical Oncology and Blood Disorders, LLP
100 Haynes Street, Manchester CT  06040
860.646.0670

Connecticut Cancer Trials Listings is a collection of clinical cancer trials in the state of Connecticut that are recruiting. This site is intended to help cancer patients and their doctors find the trials that fit their needs and to introduce patients to the world of clinical trials and give them the tools to make informed decisions.